|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 21 of 30 found articles
| Title: |
Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis |
| Author: |
Muchtar, Eli Gertz, Morie A. LaPlant, Betsy R. Buadi, Francis K. Leung, Nelson O'Brien, Patrick Bergsagel, P. Leif Fonder, Amie Hwa, Yi Lisa Hobbs, Miriam Helgeson, Dania K. Bradt, Erin E. Gonsalves, Wilson Lacy, Martha Q. Kapoor, Prashant Siddiqui, Mustaqueem Larsen, Jeremy T. Warsame, Rahma Hayman, Suzanne R. Go, Ronald S. Dingli, David Kourelis, Taxiarchis V. Dispenzieri, Angela Rajkumar, S. Vincent Kumar, Shaji K. |
| Appeared in: |
Blood advances |
| Paging: | Volume 6 () nr. 18 pages 5429-5435 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
The American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 21 of 30 found articles
| << previous | next >> |